FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and…